A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy

Abroad (travel likely)RecruitingPHASE1

Conditions

AD - Alzheimer's Disease · MCI

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Chinese PLA General Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Dr. Wang Ruimin, Doctor) · wrm@yeah.net · 86-13501151740